FOR NEW METHOD TO MAKE A DIAGNOSIS OF AUTOIMMUNE CARDIOMYOPATHY
FOR NEW METHOD TO MAKE A DIAGNOSIS OF AUTOIMMUNE CARDIOMYOPATHY
批准号:
16590713
负责人:
IZUMI Tohru
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
G蛋白通过β-肾上腺素能受体不仅作为心肌收缩性的调节剂,而且作为免疫应答的调节剂而受到关注。因此,首先,研究了抑制性G(Gi)蛋白对心肌炎症的免疫调节作用。将肌球蛋白免疫的刘易斯大鼠(EAM:实验性自身免疫性心肌炎/心肌病)分为两组:在免疫的同时(在诱导期)给予百日咳毒素(PTX),一种代表性的Gi蛋白抑制剂,另一种在免疫后(在效应期)给予。观察PTX对EAM的预防作用。随着诱导期的使用,PTX恶化了EAM。另一方面,在效应期使用,PTX改善了其疾病严重程度。这种双向G蛋白信号可能是自身免疫性心肌病的主要免疫调节途径之一,而促红细胞生成素(EPO)对心肌损伤具有保护作用。因此,第二,研究EPO对心肌炎症的免疫调节作用。EAM大鼠每天用任一EPO处理。EPO显著降低EAM的严重程度,同时降低心肌中IFN-γ/肌钙蛋白T和IL-10/TNTmRNA。虽然EPO没有抑制肌球蛋白特异性的,在体外的心肌原性T细胞的增殖,EAM产生的静脉内转移的这些T细胞的改善,每天给予EPO。促红细胞生成素(EPO)在效应期具有抗炎作用,将Gi蛋白作为β刺激信号和促红细胞生成素作为内源性体液因子,建立诊断自身免疫性心肌炎的新方法。
英文摘要
The G protein through β-adrenergic receptors has been focused on as a modulator of not only myocardial contractility but also immune response. Thus, firstly, the immunomodulatory effects of the inhibitory G (Gi) protein on myocardial inflammation are studied. Myosin-immunized Lewis rats (EAM : experimental autoimmune myocarditis/cardiomyopathy) were divided into two groups : administered with pertussis toxin (PTX), a representative Gi protein inhibitor, simultaneously with immunization (in induction phase) and the other administered after immunization (in effector phase). They were evaluated adjunctive effect of PTX on EAM. With the use in induction phase, PTX deteriorated EAM. On the other hand, in the use in effector phase, PTX improved its disease severity. This bidirectional G protein signal must be one of the major immunomodulating pathways in autoimmune cardiomyopathy.On the other hand, erythropoietin (EPO) has a protective effect on myocardial damage. Thus, secondly, immunomodulatory effects of EPO on myocardial inflammation were investigated. EAM rats were treated daily with either EPO. EPO markedly reduced severity in EAM with the reduction of IFN-gamma/troponin T and IL-10/TNTmRNA in the myocardium. Although EPO did not suppress the proliferation of myosin-specific, myocarditogenic T cells in vitro, EAM produced by intravenous transfer of those T cells were ameliorated by daily administration of EPO. EPO has anti-inflammatory effect on the effecter phase.For establishment of new method to make a diagnosis of autoimmune myocarditis in human being, the above mentioned two points are taken into account : Gi protein signal as beta-stimulation and erythropoietin as an intrinsic humoral factor.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
カテコラミン心筋症・心筋炎
儿茶酚胺心肌病/心肌炎
DOI:
--
发表时间:
2004
期刊:
Heart View 8(6)
影响因子:
--
作者:
[西井基継, 和泉 徹]
通讯作者:
和泉 徹
Distinguishable OptiInal Levels of Plasma B-type Natriuretic Peptide in Heart Failure Management Based on Complicated Atrial Fibrillation
基于复杂心房颤动的心力衰竭治疗中血浆 B 型利钠肽的最佳可区分水平
DOI:
--
发表时间:
2005
期刊:
International Heart Journal 46・3
影响因子:
--
作者:
[Toshimi Koitabashi, Takayuki Inomata, Tohru Izumi et al.]
通讯作者:
Tohru Izumi et al.
DOI:
10.1253/circj.69.823
发表时间:
2005-07-01
期刊:
CIRCULATION JOURNAL
影响因子:
3.3
作者:
[Koitabashi, T, Inomata, T, Izumi, T]
通讯作者:
Izumi, T
DOI:
10.1536/ihj.46.513
发表时间:
2005-05-01
期刊:
INTERNATIONAL HEART JOURNAL
影响因子:
1.5
作者:
[Maeda, K, Shioi, T, Izumi, T]
通讯作者:
Izumi, T
DOI:
10.1016/j.cardiores.2004.04.020
发表时间:
2004-09-01
期刊:
CARDIOVASCULAR RESEARCH
影响因子:
10.8
作者:
[Wakisaka, Y, Niwano, S, Izumi, T]
通讯作者:
Izumi, T
共 8 条
Studies on the Cell Kinetics of Cardiac Dendritic Cell
-
批准号:22590812
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2010
-
负责人:IZUMI Tohru
-
依托单位:
A MOLECULAR BIOLOGICAL STUDY ON CARDIAC DENDRITIC CELL OF THE AUTOIMMUNE CARDIOMYOPATHY
-
批准号:11838015
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:IZUMI Tohru
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: